Novacyt: Edwin Snape
Dec 07, 2022
Edwin Snape will retire from the board of directors of Novacyt after 14 years, effective Dec. 31. He was a non-executive director for Novacyt and formerly for Lab21, which Novacyt acquired in 2014. Snape is a cofounder of Nexus NMT Capital, formerly Nexus Medical Partners, and continues to serve as a senior adviser to that firm. He previously served as managing general partner of private equity firm Vista Group and as chairman of private equity firm Orien Ventures. He was also a director of UK-based private equity firm Cygnus Funds and founded pharmaceutical firm The Liposome Company.